Open access
Open access
Powered by Google Translator Translator

All Posts

UAE says Chinese vaccine 86% effective, offers few details

10 Dec, 2020 | 08:43h | UTC

UAE says Chinese vaccine 86% effective, offers few details – Associated Press

See also: China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says – Bloomberg

 


UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions

10 Dec, 2020 | 08:41h | UTC

UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions – Reuters

See also: UK probes whether COVID-19 vaccine caused allergic reactions – Associated Press AND NHS told not to give Covid vaccine to those with history of allergic reactions – The Guardian

 


CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

9 Dec, 2020 | 08:23h | UTC

CDC Releases New Ventilation Guidelines For Indoor Environments To Reduce Covid-19 Risk – Forbes

CDC Guideline: Ventilation

Related podcast: Air Handling Standards for Increasing the Safety of Indoor Spaces During the COVID-19 Pandemic – JAMA

 


Vast majority of pregnant women with COVID-19 won’t have complications, study finds

10 Dec, 2020 | 08:39h | UTC

Vast Majority of Pregnant Women with COVID-19 Won’t Have Complications, Study Finds – NIH Director’s Blog

Original study: Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection – JAMA Network Open

 


Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen

9 Dec, 2020 | 08:25h | UTC

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet

Commentaries: Oxford COVID vaccine paper highlights lingering unknowns about results – Nature AND Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy – STAT AND Oxford–AstraZeneca COVID-19 vaccine efficacy – The Lancet AND Oxford COVID-19 vaccine is safe and protects against disease, first published results from phase 3 trials – The Lancet AND Expert reaction to a study on the results of phase 3 human trials of the Oxford/AZ COVID-19 vaccine – Science Media Centre

 


How rich countries are ‘hoarding’ the world’s vaccines, in charts

10 Dec, 2020 | 08:40h | UTC

How Rich Countries Are ‘Hoarding’ The World’s Vaccines, In Charts – NPR

See also: How COVID vaccines are being divvied up around the world – Nature AND Rich countries hoarding Covid vaccines, says People’s Vaccine Alliance – BBC AND Amnesty: rich countries have bought too many COVID-19 vaccines – Reuters

 


“COVID-19: when are you most infectious?” This commentary from the authors of a recent meta-analysis highlights the findings that infectiousness peaks within the first 5 days of symptom onset

10 Dec, 2020 | 08:38h | UTC

COVID-19: when are you most infectious? – The Conversation

Original study and commentaries: Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset

 


Report: Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

9 Dec, 2020 | 08:20h | UTC

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic – Science

Commentary: tudy of virus attack rate in Manaus, Brazil, shows outcome of mostly unmitigated epidemic – American Association for The Advancement Of Science

 


FDA Safety Communication: Wear face masks with no metal during MRI exams

9 Dec, 2020 | 08:21h | UTC

Wear Face Masks with No Metal During MRI Exams: FDA Safety Communication – U.S. Food & Drug Administration

Commentary: Any mask containing metal could cause burns during an MRI, FDA warns – MedicalXpress

 


“Neurological manifestations of COVID-19” – guideline of the German society of neurology

9 Dec, 2020 | 08:15h | UTC

“Neurological manifestations of COVID-19” – guideline of the German society of neurology – Neurological Research and Practice

 


Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19

9 Dec, 2020 | 08:19h | UTC

Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial – Annals of Internal Medicine

Summary for patients: Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection

 


New vaccine data is coming: Watch out for these 3 claims

9 Dec, 2020 | 08:17h | UTC

New Vaccine Data Is Coming: Watch Out for These 3 Claims – Wired

 


Review: Cardiopulmonary impact of particulate air pollution in high-risk populations

9 Dec, 2020 | 08:07h | UTC

Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review – Journal of the American College of Cardiology

Commentary: Air Pollution a Public Health Threat; Strategies to Reduce Exposure Needed, JACC Review Paper Says – American College of Cardiology

 


Randomized trial: No benefit and potential harm from Vitamin D at doses of 1000 IU/d or higher compared with 200 IU/d in older persons with elevated fall risk

9 Dec, 2020 | 08:13h | UTC

The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults: A Response-Adaptive, Randomized Clinical Trial – Annals of Internal Medicine

Commentaries: Study Finds No Benefit, Possible Harm to Seniors’ Fall Risks with Higher Doses of Vitamin D – Johns Hopkins Medicine AND Does High-Dose Vitamin D Actually Heighten Fall Risk? – Physician’s Weekly

 

Commentary on Twitter (thread – click for more)

https://twitter.com/ErinMichos/status/1336091776994537472

 


Cohort study: In the general population, both low and high levels of LDL cholesterol were associated with an increased risk of all-cause mortality

9 Dec, 2020 | 08:11h | UTC

Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study – The BMJ

 

Commentary on Twitter

 


If exposed to Covid-19, how long before you have symptoms? Median incubation is 5.1 days, and 97.5% of those who develop symptoms do so within 11.5 days of being exposed to the virus

8 Dec, 2020 | 08:06h | UTC

If Exposed To Covid-19 Coronavirus, How Long Before You Have Symptoms – Forbes

 


WHO Manifesto: Prescriptions and actionables for a healthy and green recovery from Covid-19

8 Dec, 2020 | 08:13h | UTC

WHO manifesto for a healthy recovery from COVID-19 – World Health Organization

 

Commentary on Twitter

 


WHO set to approve a COVID-19 vaccine by the end of 2020—increasing hopes for equitable access

8 Dec, 2020 | 08:09h | UTC

WHO set to approve a COVID-19 vaccine by end of 2020—increasing hopes for equitable access – National Geographic

 


Opinion: “Get ready for vaccine false side effects”. When millions of people are vaccinated, naturally occurring health problems could be wrongly attributed to vaccines

8 Dec, 2020 | 07:55h | UTC

Get Ready for False Side Effects – Science Translational Medicine

 


Data from 45 countries show containing COVID vs. saving the economy is a false dichotomy

8 Dec, 2020 | 07:57h | UTC

Data from 45 countries show containing COVID vs saving the economy is a false dichotomy – The Conversation

 


First-of-its-kind African trial tests common drugs to prevent severe COVID-19. “Could cheap, widely available drugs prevent patients with mild illness from becoming severely sick?”

8 Dec, 2020 | 07:46h | UTC

First-of-its-kind African trial tests common drugs to prevent severe COVID-19 – Science

 


Observational study: Even low dose oral glucocorticoids linked to increased cardiovascular risk in people with immune-mediated inflammatory diseases

8 Dec, 2020 | 07:35h | UTC

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study – PLOS Medicine

Commentary: Patients receiving low dose steroid at increased risk of cardiovascular disease – Public Library of Science

 


Randomized trial: In pregnant women with mild and moderate chronic hypertension, the use of labetalol was associated with more adverse events compared to methyldopa or no medication

8 Dec, 2020 | 07:26h | UTC

Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial – Hypertension in Pregnancy

Commentary: Methyldopa versus labetalol or no medication for the treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial – Physician’s Weekly

 


How to write a superb literature review

8 Dec, 2020 | 07:32h | UTC

How to write a superb literature review – Nature

 


New CDC Guidance with 10 public health strategies to address high levels of community transmission of SARS-Cov-2, including universal use of face masks

7 Dec, 2020 | 01:10h | UTC

Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020 – CDC Morbidity and Mortality Weekly Report

Commentaries: Masks are critical to stopping coronavirus spread, even at home, CDC says – CNN AND CDC recommends ‘universal’ use of face masks to prevent COVID-19 spread – UPI

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.